EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Financial Indicator Details
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ 長谷川香料 +
@ エスケー化研 +
@ Toray Industries +
@ Takeda Pharmaceutical +
@ 持田製薬 +
@ ダイセル +
@ Mitsubishi Tanabe Pharma +
@ Hitachi Chemical +
@ MANDOM +
@ ADEKA +
@ Sekisui Chemical +
@ キッセイ薬品工業 +
@ 東京応化工業 +
@ Dainippon Sumitomo Pharma +
@ アステラス製薬 +
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-03 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
Nittetsu Mining
graph
SANKEI CHEMICAL
graph
PIONEER
graph
クラリオン
graph
クラリオン
graph

Financial Indicator Details: アステラス製薬 (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

*Free Download Financial Indicator data

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability2009-03-312010-03-312011-03-312012-03-312013-03-31
Net profit margin
(Industry Average)
17.70%
(-12.05%)
12.54%
(-0.50%)
7.09%
(1.53%)
8.07%
(-1.67%)
8.23%
(3.05%)
C/F margin
(Industry Average)
20.48%
(-3.31%)
15.39%
(8.51%)
10.54%
(7.04%)
17.81%
(6.35%)
14.33%
(8.25%)
ROA
(Industry Average)
12.68%
(0.52%)
8.96%
(1.04%)
5.06%
(2.07%)
5.58%
(0.06%)
5.73%
(2.71%)
ROE
(Industry Average)
16.59%
(-1.43%)
11.60%
(0.03%)
6.62%
(2.96%)
7.68%
(4.68%)
7.80%
(4.57%)
Growth2009-03-312010-03-312011-03-312012-03-312013-03-31
Equity growth
(Industry Average)
-
(-)
2.30%
(5.01%)
-3.11%
(2.61%)
-0.29%
(-0.40%)
4.31%
(8.16%)
Sales growth
(Industry Average)
-
(-)
0.95%
(-2.67%)
-2.14%
(5.36%)
1.61%
(1.07%)
3.73%
(2.24%)
Net profit growth
(Industry Average)
-
(-)
-28.49%
(203.46%)
-44.66%
(63.25%)
15.63%
(3.89%)
5.90%
(90.38%)
Operating C/F growth
(Industry Average)
-
(-)
-24.09%
(275.10%)
-32.96%
(35.09%)
71.57%
(-6.09%)
-16.51%
(138.39%)
Stability2009-03-312010-03-312011-03-312012-03-312013-03-31
Capital adequacy
(Industry Average)
76.40%
(53.80%)
77.25%
(54.51%)
76.48%
(55.00%)
72.69%
(53.59%)
73.46%
(56.30%)
Liquidity ratio
(Industry Average)
339.84%
(217.72%)
356.67%
(225.70%)
272.54%
(237.55%)
248.61%
(239.89%)
263.82%
(236.21%)
C/F ratio current liabilities
(Industry Average)
143.35%
(777.21%)
184.61%
(303.31%)
238.12%
(434.79%)
181.94%
(929.73%)
217.50%
(573.30%)
Quick ratio
(Industry Average)
172.96%
(138.97%)
194.93%
(148.85%)
169.16%
(156.17%)
151.40%
(160.84%)
165.81%
(156.81%)
Turnover2009-03-312010-03-312011-03-312012-03-312013-03-31
Receivables turnover
(Industry Average)
84.27day
(83.89day)
85.39day
(94.27day)
100.44day
(93.96day)
99.66day
(97.92day)
103.83day
(98.27day)
Inventory turnover
(Industry Average)
39.84day
(54.45day)
41.57day
(52.58day)
44.72day
(52.64day)
42.10day
(56.59day)
46.52day
(58.68day)
Payable turnover
(Industry Average)
33.92day
(45.01day)
31.45day
(49.82day)
33.90day
(49.52day)
40.81day
(52.10day)
37.32day
(51.12day)
Working capita turnover
(Industry Average)
90.19day
(93.32day)
95.51day
(97.02day)
111.26day
(97.08day)
100.94day
(102.41day)
113.03day
(105.83day)
Stock etc.2009-03-312010-03-312011-03-312012-03-312013-03-31
Market Value growth
(Industry Average)
-
(-)
5.85%
(34.57%)
-10.53%
(1.49%)
10.38%
(-3.85%)
48.82%
(21.16%)
Dividend Yield
(Industry Average)
3.98%
(3.20%)
3.61%
(1.93%)
4.00%
(2.17%)
3.62%
(2.45%)
2.53%
(2.07%)
PER
(Industry Average)
8.90%
(25.22%)
13.17%
(23.06%)
21.30%
(16.22%)
20.33%
(29.19%)
28.58%
(16.58%)
PBR
(Industry Average)
1.47%
(0.86%)
1.52%
(1.06%)
1.41%
(1.04%)
1.56%
(0.95%)
2.22%
(1.08%)
PCFR
(Industry Average)
7.69%
(7.18%)
10.73%
(9.23%)
14.32%
(-2.43%)
9.21%
(9.50%)
16.42%
(7.56%)
PSR
(Industry Average)
1.57%
(0.77%)
1.65%
(0.88%)
1.51%
(1.10%)
1.64%
(0.90%)
2.35%
(1.01%)

Financial Indicator Details: アステラス製薬

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Profitability
Net profit margin17.70%12.54%7.09%8.07%8.23%
C/F margin20.48%15.39%10.54%17.81%14.33%
ROA12.68%8.96%5.06%5.58%5.73%
ROE16.59%11.60%6.62%7.68%7.80%
Recurring margin28.10%19.59%12.06%13.93%15.62%
EBIT margin26.17%18.87%10.74%12.99%12.35%
EBITDA margin29.84%22.84%16.45%18.54%17.08%
NOPAT margin15.70%11.32%6.44%7.79%7.41%
Sales SG rates27.38%29.66%31.02%32.86%32.23%
Sales SG&A rates46.68%51.20%56.48%53.56%52.46%
Sales R&D expenses rates16.47%20.06%---
Sales depreciation rates3.66%3.96%5.71%5.54%4.72%
Capital expenditures net sales ratio-3.79%-4.05%-3.52%-4.91%-3.11%
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Growth
Growth rate of cash-16.72%-54.22%47.65%10.81%
Equity growth-2.30%-3.11%-0.29%4.31%
Total assets growth-1.16%-2.13%4.90%3.20%
Sales growth-0.95%-2.14%1.61%3.73%
Net profit growth--28.49%-44.66%15.63%5.90%
Operating C/F growth--24.09%-32.96%71.57%-16.51%
Recurring profit growth--29.64%-39.75%17.42%16.31%
EBIT growth--27.19%-44.31%22.93%-1.35%
EBITDA growth--22.72%-29.49%14.48%-4.41%
NOPAT growth--27.19%-44.31%22.93%-1.35%
Operating expenses growth-----
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Stability
Capital adequacy76.40%77.25%76.48%72.69%73.46%
Liquidity ratio339.84%356.67%272.54%248.61%263.82%
C/F ratio current liabilities143.35%184.61%238.12%181.94%217.50%
Quick ratio172.96%194.93%169.16%151.40%165.81%
Fixed ratio17.61%17.50%18.62%19.56%20.57%
D/E ratio-----
Loan to Value Ratio-----
Business investment C/F ratio-18.53%-26.32%-33.41%-27.61%-21.73%
Liabilities with interest growth-----
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Turnover
Cash turnover101.09day116.88day54.67day79.44day84.86day
Receivables turnover84.27day85.39day100.44day99.66day103.83day
Inventory turnover39.84day41.57day44.72day42.10day46.52day
Fixed assets turnover68.58day69.07day72.75day74.98day79.29day
Total asset turnover509.66day510.75day510.83day527.37day524.68day
Payable turnover33.92day31.45day33.90day40.81day37.32day
Capital turnover38.93day38.56day39.40day38.78day37.38day
Equity turnover389.38day394.59day390.69day383.35day385.47day
Working capita turnover90.19day95.51day111.26day100.94day113.03day
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Balance sheet
Cash etc.¥ 267 B¥ 312 B¥ 142 B¥ 210 B¥ 233 B
Accounts receivable-trade¥ 222 B¥ 228 B¥ 262 B¥ 264 B¥ 286 B
Other Current Assets¥ 696 B¥ 676 B¥ 510 B¥ 570 B¥ 593 B
Current Assets¥ 963 B¥ 988 B¥ 653 B¥ 781 B¥ 827 B
Tangible Assets¥ 181 B¥ 184 B¥ 190 B¥ 199 B¥ 218 B
Intangible Assets¥ 58 B¥ 62 B¥ 367 B¥ 314 B¥ 294 B
Investment etc.¥ 144 B¥ 128 B¥ 124 B¥ 106 B¥ 105 B
Total Assets¥ 1.3 T¥ 1.3 T¥ 1.3 T¥ 1.4 T¥ 1.4 T
Current Liabilities¥ 283 B¥ 277 B¥ 239 B¥ 314 B¥ 313 B
Fixed Liabilities¥ 34 B¥ 33 B¥ 74 B¥ 68 B¥ 69 B
Liabilities with interest-----
Net Assets¥ 1.0 T¥ 1.0 T¥ 1.0 T¥ 1.0 T¥ 1.0 T
Capital stock¥ 103 B¥ 103 B¥ 103 B¥ 103 B¥ 103 B
Capital surplus etc.¥ 927 B¥ 950 B¥ 918 B¥ 915 B¥ 959 B
Liabilities and net assets¥ 1.3 T¥ 1.3 T¥ 1.3 T¥ 1.4 T¥ 1.4 T
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Income statement
Sales¥ 965 B¥ 974 B¥ 953 B¥ 969 B¥ 1.0 T
Cost of Sales¥ 264 B¥ 289 B¥ 295 B¥ 318 B¥ 324 B
Gross profit¥ 701 B¥ 685 B¥ 657 B¥ 650 B¥ 681 B
Other income¥ 24 B¥ 8 B¥ 4 B¥ 18 B¥ 9 B
SG&A¥ 450 B¥ 499 B¥ 538 B¥ 519 B¥ 527 B
Other expenses¥ 101 B¥ 70 B¥ 56 B¥ 71 B¥ 80 B
Net income¥ 170 B¥ 122 B¥ 67 B¥ 78 B¥ 82 B
Operating income¥ 250 B¥ 186 B¥ 119 B¥ 131 B¥ 153 B
Ordinary Income¥ 271 B¥ 190 B¥ 115 B¥ 135 B¥ 157 B
EBITDA¥ 288 B¥ 222 B¥ 157 B¥ 179 B¥ 171 B
Income before income taxes¥ 262 B¥ 186 B¥ 103 B¥ 127 B¥ 124 B
Depreciation¥ 35 B¥ 38 B¥ 54 B¥ 53 B¥ 47 B
R&D expenses¥ 159 B¥ 195 B---
Income taxes¥ 89 B¥ 62 B¥ 35 B¥ 48 B¥ 41 B
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Cash flow statement
Operating CF¥ 197 B¥ 150 B¥ 100 B¥ 172 B¥ 144 B
Investment CF¥ -28 B¥ -31 B¥ -242 B¥ -25 B¥ -48 B
Financial CF¥ -184 B¥ -85 B¥ -93 B¥ -57 B¥ -109 B
Foreign Exchange Effects¥ -34 B¥ -10 B¥ -21 B¥ -11 B¥ 26 B
Net Change in Cash¥ -50 B¥ 22 B¥ -256 B¥ 76 B¥ 12 B
Free CF¥ 168 B¥ 118 B¥ -142 B¥ 146 B¥ 95 B
Capital expenditures¥ -36 B¥ -39 B¥ -33 B¥ -47 B¥ -31 B
Cash dividends paid¥ -60 B¥ -58 B¥ -57 B¥ -57 B¥ -60 B
Repayment loans-----
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Shareowners' equity
Issuance of new shares-----
Dividends from surplus¥ -58 B¥ -56 B¥ -57 B¥ -57 B¥ -60 B
Net income¥ 170 B¥ 122 B¥ 67 B¥ 78 B¥ 82 B
Purchase of treasury stock¥ -123 B¥ -26 B¥ -5 M¥ 244 M¥ -49 B
Other Change in Stockholders Equity¥ -1 M¥ -1 M-¥ 1 M-
Other Change in Net Assets¥ -69 B¥ -15 B¥ -42 B¥ -23 B¥ 70 B
Net Change in Net Assets¥ -80 B¥ 23 B¥ -32 B¥ -2 B¥ 43 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: アステラス製薬 (Annual )

Statement Type
Annual : アステラス製薬
First quarter : アステラス製薬
Second quarter : アステラス製薬
Third quarter : アステラス製薬
Analysis Menu
@Outline : アステラス製薬
@Statement : アステラス製薬
@Rating : アステラス製薬
@Indicator : アステラス製薬
@Download : アステラス製薬
Industry Comparison Ranking
Chemicals - EDIUNET Industry Rankings
Chemicals - EDIUNET Credit Rating
Chemicals - EDIUNET Industry Avg
Comparison with a neighboring company
Tokyo - EDIUNET Prefectures
Tokyo中央区 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/23 Milbon AA→AAA 2013-12-20
1/17 Kawaguchi Chemical Indu.. BBB→BB 2013-11-30
1/17 SANKEI CHEMICAL A 2013-11-30
1/15 HOKKO CHEMICAL INDUSTRY BB→B 2013-11-30
1/15 Daito Pharmaceutical Co . AA 2013-11-30 (Q2)
1/15 KAWAKAMI PAINT MFG. B→BB 2013-11-30
1/15 旭化学工業 AA 2013-11-30 (Q1)
1/10 OSAKA ORGANIC CHEMICAL .. BB→BBB 2013-11-30
1/10 HISAMITSU PHARMACEUTICAL A 2013-11-30 (Q3)
1/10 AMS Life Science BBB→BB 2013-11-30 (Q1)

Ticker Market Industry Month report Rating
@ アステラス製薬 4503 TSE 1st Chemicals 3 Annual A

Related Company

@ Sekisui Chemical (Sales ¥ 1.0 T) +
@ Nichi-Iko Pharmaceutical (Sales ¥ 93 B) +
@ 富士製薬工業 (Sales ¥ 25 B) +
@ 長谷川香料 (Sales ¥ 45 B) +
@ NIPPON KAYAKU (Sales ¥ 128 B) +
@ エスケー化研 (Sales ¥ 82 B) +
@ Mitsubishi Tanabe Pharma (Sales ¥ 419 B) +
@ アステラス製薬 (Sales ¥ 1.0 T) +
@ キョーリン製薬ホールディングス (Sales ¥ 107 B) +
@ Takeda Pharmaceutical (Sales ¥ 1.5 T) +
@ Aica Kogyo (Sales ¥ 101 B) +
@ 持田製薬 (Sales ¥ 89 B) +
@ TSUMURA & CO. (Sales ¥ 105 B) +

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.101 sec.)